CN Stock MarketDetailed Quotes

688319 Chengdu Olymvax Biopharmaceuticals Inc

Watchlist
  • 8.56
  • +0.07+0.82%
Market Closed May 17 15:00 CST
3.48BMarket Cap-285333P/E (TTM)

Chengdu Olymvax Biopharmaceuticals Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Product Currency:CNY
2023/FY
Stock NameRevenueRatio
吸附破伤风疫苗462.96M93.32%
Haemophilus influenzae type b combined vaccine27.27M5.50%
Group A C Meningococcal Polysaccharide binding Vaccine3.88M0.78%
Other business1.83M0.37%
精制破伤风类毒素原液177.99K0.04%
Industry Currency:CNY
2023/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing industry494.29M99.63%
Other1.83M0.37%
Region Currency:CNY
2023/FY
Stock NameRevenueRatio
East China182.28M36.74%
Central China108.16M21.80%
Southwest86.46M17.43%
South China51.6M10.40%
North China37.1M7.48%
Northwest19.08M3.85%
Northeast China9.61M1.94%
Other business1.83M0.37%
Other--
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg